CAS NO: | 36840-10-5 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
1mg | 电议 |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
生物活性 | LPA2 antagonist 2 (H2L 5226501) is a selectiveLPA2antagonist with anIC50of 28.3 nM and aKiof 21.1 nM. LPA2 antagonist 2 is >480-fold more selective than LPA3(IC50of 13.85 μM)[1]. | ||||||||||||||||
IC50& Target | IC50: 28.3 nM (LPA2); 13.85 μM (LPA3)[1] | ||||||||||||||||
体外研究 (In Vitro) | Lysophosphatidic acid (LPA) is a phospholipid mediator that elicits a host of biological effects including cell proliferation, survival, motility and differentiation. LPA has been shown to regulate cancer cell invasion, metastasis, and resistance to both chemotherapeutics and radiation. LPA2 antagonist 2 (H2L 5226501) inhibits LPA1with an Imax of 59.0% at 30 μM[1]. | ||||||||||||||||
分子量 | 380.35 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C20H16N2O6 | ||||||||||||||||
CAS 号 | 36840-10-5 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 83.33 mg/mL(219.09 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |